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Quality control systems facilitate polypeptide folding and degradation to maintain protein homeostasis. Molecular
chaperones promote folding, whereas the ubiquitin/proteasome system mediates degradation. We show here that
Saccharomyces cerevisiae Ubr1 and Ubr2 ubiquitin ligases promote degradation of unfolded or misfolded cytosolic
polypeptides. Ubr1 also catalyzes ubiquitinylation of denatured but not native luciferase in a purified system. This
activity is based on the direct interaction of denatured luciferase with Ubr1, although Hsp70 stimulates polyubiquitiny-
lation of the denatured substrate. We also report that loss of Ubr1 and Ubr2 function suppressed the growth arrest
phenotype resulting from chaperone mutation. This correlates with increased protein kinase maturation and indicates
partitioning of foldable conformers toward the proteasome. Our findings, based on the efficiency of this quality control
system, suggest that the cell trades growth potential to avert the potential toxicity associated with accumulation of
unfolded or misfolded proteins. Ubr1 and Ubr2 therefore represent E3 components of a novel quality control pathway for
proteins synthesized on cytosolic ribosomes.
INTRODUCTION
The relative contribution of molecular chaperones and ubiq-
uitin ligases to cellular quality control promotes proteome
homeostasis (Wickner et al., 1999; Balch et al., 2008). Their
combined action manifests in a quality control process that
is best characterized for the endoplasmic reticulum (ER),
where several chaperone and ubiquitin ligase assemblies
ensure prompt degradation of misfolded proteins (Vembar
and Brodsky, 2008). Less is known regarding quality control
of polypeptides synthesized on cytosolic ribosomes. The
ubiquitin ligase CHIP interacts with heat shock protein 70
(Hsp70) and Hsp90 molecular chaperones to promote deg-
radation of misfolded or unfolded polypeptides (Connell et
al., 2001; Meacham et al., 2001). Degradation still occurs in
CHIP / cells, however, indicating that other ubiquitin
ligases function in a redundant manner (Xu et al., 2002). In
addition, there is no CHIP homologue in yeast despite rapid
degradation of misfolded cytosolic proteins.
The role of molecular chaperones in promoting polypep-
tide folding is well established (Young et al., 2004). Results
from recent studies also suggest that Hsp70, Hsp90, and
several cochaperones function in polypeptide degradation
(McClellan et al., 2005; Arndt et al., 2007). Recently, two
molecular chaperones have been shown to protect newly
synthesized protein kinases from degradation during or
shortly after translation. Both Cdc37 and Ydj1 adopt this role
and protect against a biphasic degradation process (Mandal
et al., 2007, 2008). The first phase is very rapid on a timescale of
5 min or less (within the time taken for a pulse-labeling reac-
tion) and appears to be the same “zero-point” effect as de-
scribed by Varshavsky and colleagues (Baker and Varshavsky,
1991; Suzuki and Varshavsky, 1999; Xie and Varshavsky, 2002).
Polypeptides degraded in the second phase have a half-life of
20 min. What remains unknown are the components that
mediate the selection of misfolded proteins for the different
types of degradation. Previous studies suggested that Ubc4
and Ubc5 ubiquitin-conjugating enzymes function in the clear-
ance of misfolded polypeptides in the cytosol (Seufert and
Jentsch, 1990), but the identities of the ubiquitin ligases, apart
from CHIP, have not been reported.
Ubr1 is an ubiquitin ligase previously shown to function
in N-end rule degradation (Bartel et al., 1990). This process,
described by Varshavsky and colleagues, facilitates degra-
dation of polypeptides by recognizing destabilizing N-ter-
minal amino acids (Mogk et al., 2007). Bulky hydrophobic
and basic amino acids such as phenylalanine or arginine,
promote degradation via Ubr1, whereas others, such as me-
thionine, are stabilizing and protect against degradation. In
addition, Ubr1 also functions in N-end rule independent
degradation (Du et al., 2002) and was shown recently by
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Table 1. Yeast strains used in this study
Strain MAT Genotype Source
BY4741 a his31 leu20 met150 ura30 Open Biosystems
S288C a his31 leu20 met150 ura30 Open Biosystems
Tpk2-TAP a S288C, TPK2-TAP (HIS3) Open Biosystems
Cmk2-TAP a S288C, CMK2-TAP (HIS3) Open Biosystems
Cup9-TAP a S288C, CUP9-TAP (HIS3) Open Biosystems
Rim11-TAP a S288C, RIM11-TAP (HIS3) Open Biosystems
Kss1-TAP a S288C, KSS1-TAP (HIS3) Open Biosystems
NNY1 a S288C, TPK2-TAP (HIS3) erg6::kanMX6 This study
NNY2 a S288C, TPK2-TAP (HIS3) erg6::natMX4 This study
NNY3 a S288C, CMK2-TAP (HIS3) erg6::kanMX6 This study
NNY4 a S288C, CUP9-TAP (HIS3), erg6::natMX4 This study
NNY5 a S288C, RIM11-TAP (HIS3) erg6::kanMX6 This study
NNY6 a S288C, KSS1-TAP (HIS3) erg6::kanMX6 This study
NNY7 a BY4741, erg6::natMX4, pTPK2 NT-HA 1.111 (LEU2) This study
NNY8 a BY4741, ubr1::kanMX6, erg6::natMX4, pTPK2 NT-HA 1.111 (LEU2) This study
NNY9 a BY4741, ubr2::kanMX6, erg6::natMX4, pTPK2 NT-HA 1.111 (LEU2) This study
NNY10 a BY4741, ubr1::kanMX6, ubr2::HIS3, erg6::natMX4, pTPK2 NT-HA 1.111 (LEU2) This study
NNY11 a S288C, TPK2-TAP (HIS3) cdc37S14A::URA3 erg6::kanMX6 This study
NNY12 a BY4741, ubr1::kanMX6, erg6::natMX4, pNTFlagUBR1 (LEU2) This study
JN516  his3-11, 3-15, leu2-3,2-112, ura3-52, trp1-1, lys2, SSA1, ssa2::LEU2 ssa3::TRP1
ssa4::LYS2
E. Craig
ssa1-45  his3-11, 3-15, leu2-3,2-112, ura3-52, trp1-1, lys2, ssa1-45, ssa2::LEU2 ssa3::TRP1
ssa4::LYS2
E. Craig
NNY13 a S288C, TPK2-TAP (HIS3) erg6::natMX4 ubr1::kanMX6 This study
NNY14 a S288C, RIM11-TAP (HIS3) erg6::natMX4 ubr1::kanMX6 This study
NNY15 a S288C, KSS1-TAP (HIS3) erg6::natMX4 ubr1::kanMX6 This study
NNY16 a S288C, TPK2-TAP (HIS3) erg6::natMX4 ubr2::kanMX6 This study
NNY17 a S288C, RIM11-TAP (HIS3) erg6::natMX4 ubr2::kanMX6 This study
NNY18 a S288C, KSS1-TAP (HIS3) erg6::natMX4 ubr2::kanMX6 This study
NNY19 a S288C, TPK2-TAP (HIS3) cdc37S14A::URA3 This study
NNY20 a S288C, TPK2-TAP (HIS3) cdc37S14A::URA3, ubr1::kanMX6, This study
NNY21 a S288C, TPK2-TAP (HIS3) cdc37S14A::URA3, ubr2::kanMX6, This study
NNY22 a S288C, TPK2-TAP (HIS3) cdc37S14A::URA3, ubr1::kanMX6, ubr2::natMX4 This study
ubr1 a BY4741, ubr1::kanMX6 Open Biosystems
ubr2 a BY4741, ubr2::kanMX6 Open Biosystems
NNY23 a BY4741, ubr1::kanMX6, ubr2::HIS3 This study
NNY24 a BY4741, cdc37S14A::natMX4 This study
NNY25 a BY4741, cdc37S14A::natMX4, ubr1::kanMX6 This study
NNY26 a BY4741, cdc37S14A::natMX4, ubr2::kanMX6 This study
NNY27 a BY4741, cdc37S14A::natMX4, ubr1::kanMX6, ubr2::HIS3 This study
NNY28 a BY4741, pHis-Ste11N K444R (URA3) This study
NNY29 a BY4741, cdc37S14A::natMX4, pHis-Ste11N K444R (URA3) This study
NNY30 a BY4741, cdc37S14A::natMX4, ubr1::kanMX6, pHis-Ste11N K444R (URA3) This study
NNY31 a BY4741, cdc37S14A::natMX4, ubr2::kanMX6, pHis-Ste11N K444R (URA3) This study
NNY32 a BY4741, cdc37S14A::natMX4, ubr1::kanMX6, ubr2:HIS3, pHis-Ste11N K444R (URA3) This study
NNY33 a BY4741, erg6::natMX4 pRS313 TPK2 NT-HA (HIS3) This study
NNY34 a BY4741, ubr1::kanMX6, erg6::natMX4 pRS313 TPK2 NT-HA (HIS3) This study
NNY35 a BY4741, rad6::kanMX6, erg6::natMX4 pRS313 TPK2 NT-HA (HIS3) This study
NNY36 a BY4741, ubc4::kanMX6, erg6::natMX4 pRS313 TPK2 NT-HA (HIS3) This study
NNY37 a BY4741, ubc5::kanMX6, erg6::natMX4 pRS313 TPK2 NT-HA (HIS3) This study
NNY38 a BY4741, ate1::kanMX6, erg6::natMX4 pRS313 TPK2 NT-HA (HIS3) This study
nta1 a BY4741, nta1::kanMX6 Open Biosystems
NNY39 a BY4741 cdc37S14A::natMX4, nta1::kanMX6 This study
ate1 a BY4741, ate1::kanMX6 Open Biosystems
NNY40 a BY4741 cdc37S14A::natMX4, ate1::kanMX6 This study
rad6 a BY4741, rad6::kanMX6 Open Biosystems
NNY41 a BY4741, cdc37S14A::natMX4, rad6::kanMX6 This study
ubc4 a BY4741, ubc4::kanMX6 Open Biosystems
NNY42 a BY4741, cdc37S14A ::natMX4, ubc4::kanMX6 This study
ubc5 a BY4741, ubc5::kanMX6 Open Biosystems
NNY43 a BY4741, cdc37S14A::natMX4, ubc5::kanMX6 This study
NNY44 a BY4741, pRS425 CUP1.mycUB (LEU2) This study
NNY45 a BY4741, ubr1::kanMX6, pRS425 CUP1.mycUB (LEU2) This study
NNY46 a BY4741, ubr2::kanMX6, pRS425 CUP1.mycUB (LEU2) This study
Continued
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Eisele and Wolf (2008) to act on a misfolded protein in the
cytosol. Ubr1 is a large protein with at least three distinct
substrate-binding sites and functions in association with
Ubc2/Rad6 and also Ubc4 (Byrd et al., 1998). Ubr1 has a
paralog, Ubr2, which does not have the conserved sequence
motifs required for N-end rule degradation but promotes
ubiquitinylation of Rpn4, a transcription factor involved in
regulating genes encoding proteasome subunits (Wang et al.,
2004). In this report we describe Ubr1 and Ubr2 as having a
general role in the clearance of misfolded cytosolic proteins
and show that their action is stimulated by Hsp70.
MATERIALS AND METHODS
Chemicals and Antisera
Geldanamycin (GA) was purchased from InvivoGen (San Diego, CA) and
stored at 20°C in dimethylsulphoxide. l-azetidine-2-carboxylic acid (AZC)
was purchased from Sigma (A0760; St. Louis, MO) and stored in water at
20°C. MG132 was purchased from Calbiochem (La Jolla, CA). Nourseothri-
cin was purchased from Werner BioAgents (Jena, Germany). G418 sulfate was
obtained from Alexis Biochemicals (San Diego, CA). Complete protease in-
hibitors were purchased from Roche (Indianapolis, IN). Mouse monoclonal
anti-myc (9E10) and anti-hemagglutinin (HA; 12CA5) were obtained from
the Mount Sinai Hybridoma Facility (New York, NY). Anti-Flag was
purchased from Sigma (F1804). Rabbit polyclonal anti-tap was prepared
against the peptide: CSSGALDYDIPTTASENLYFQ by Covance Research
(Madison, WI). Cdc28 was immunoprecipitated using anti-PSTAIRE (Santa
Cruz Biotechnology, Santa Cruz, CA). Hsp70 mouse monoclonal antisera
was purchased from Stressgen (spa-822; San Diego, CA). Anti-Hsp104 was
from Stressgen (SPA-1040) and goat anti-luciferase from Chemicon (AB
3256; Temecula, CA). Anti– galactosidase (ß-Gal) was purchased from
Promega (Z378A; Madison, WI).
Yeast Cell Growth Conditions
Saccharomyces cerevisiae was grown in either rich YPD media (2% [wt/vol]
Bacto peptone (Difco), 1% Bacto yeast extract (Difco), 2% glucose) or in
selective media (SD; 0.67% Yeast nitrogen base without amino acids (Difco),
2% glucose and appropriate amino acids). G418 sulfate and nourseothricin
were added to a final concentration of 400 g/ml and 100 g/ml, respec-
tively. S. cerevisiae strains used in this study are listed in Table 1.
Pulse-Chase Analysis and Immunoprecipitation
Cells were grown in selective media to midlog phase (A600  0.4–0.6),
washed twice in water, and resuspended in SD-Met (0.67% yeast nitrogen
base, 2% glucose, all amino acids minus methionine) at a concentration of 6
A600 units/ml. Cells were incubated at 30°C with shaking. GA (50 M; 45
min), AZC (50 mM; 45 min), or MG132 (100 M; 30 min) was also added at
this time depending on the experiment. The cells were aliquoted for labeling,
and [35S]methionine was added to 100 Ci/ml. Pulse-labeling was conducted
for 10 min at 30°C with shaking. The pulse was quenched with cycloheximide
(200 g/ml) and cold methionine (1 mM) for chase reactions. Pulse and chase
reactions (at various times as per individual experiments) were stopped by
taking 400 l of [35S]methionine-labeled culture and adding it to an equal
volume of ice-cold 20% trichloroacetic acid until all chase samples had been
processed.
Extracts were prepared by pelleting the cells and washing them twice in
acetone (20°C) before vacuum drying. The cells were resuspended in 200 l
ice-cold extract buffer (50 mM Tris-HCl, pH 7.5, 1% SDS, 1 mM EDTA, and 1
Complete protease inhibitors; Roche). Cells were added to an equal volume of
glass beads (0.4 mm; Biospec Products, Bartlesville, OK) and broken in a bead
beater at 4°C two times for 30 s. The extracts were quantified for 35S incor-
poration in a scintillation counter, and an equal number of counts was used
for subsequent immunoprecipitations (IPs).
Extracts were prepared for IP by first diluting them at least 10-fold into IP
dilution buffer (60 mM Tris-HCl, pH 7.5, 190 mM NaCl, 1.25% Triton-X-100,
and 6 mM EDTA). Antisera was added, and the samples incubated overnight,
rotating at 4°C. Immunoprecipitates were adsorbed onto protein A-Sepharose
resin for 1 h and washed five times in IP dilution buffer. The samples were
then dissolved in 1 SDS sample buffer and resolved by denaturing gel
electrophoresis. The gels were fixed (10% acetic acid, 30% methanol) for 30
min, washed twice in water for 15 min, and incubated in 1 M sodium
salicylate for 30 min before drying and exposing to x-ray film or phospho-
rimager screen.
Inhibition of N-end Rule Substrate-binding Sites of Ubr1
with Dipeptides
Dipeptide uptake and inhibition of Ubr1’s N-end rule substrate-binding sites
were conducted as described by Byrd et al. (1998) and Rao et al. (2001). Briefly,
S. cerevisiae strains expressing either Tap-tagged Tpk2, Arg-ß-Gal (galactose-
inducible promoter), or Tap-tagged Cup9 were grown in SHM medium
lacking histidine (2% glucose, 0.1% allantoin [Acros, Pittsburgh, PA], and
0.17% yeast nitrogen base without amino acids and without ammonium
sulfate) to an A600 of 0.6. Cells were harvested and washed twice with sterile
water and once with SHM medium lacking methionine at a concentration of
6 A600 units/ml. Then the cells were incubated for 1.5 h at 30°C in SHM
lacking methionine with 10 mM H-Leu-Ala-OH (Bachem, King of Prussia,
PA) and 10 mM H-Arg-Ala-OH (Bachem). Pulse-chase analysis of Tap-tagged
Tpk2 and Cup9 was carried out according to the protocol described above.
Tpk2 Enzyme Assay
PepTag nonradioactive detection system was used (Promega) according to
the instructions from the manufacturer.
Denaturation and Reactivation of Firefly Luciferase
Yeast strains carrying a luciferase plasmid (pRS316) under control of a galac-
tose promoter were grown overnight at 30°C to approximately A600 4–5.
Samples were diluted back then induced with 2% galactose (wt/vol) for 2 h
at midlog phase of growth. All samples were treated with 0.5 mg/ml cyclo-
heximide, incubated at 42°C for 1 h, and then returned to 30°C. At the
indicated time points, cells at 0.6 A600 were collected for lysis (in lysis buffer
containing 0.1% Triton-X-100 and broken in bead beater) and protein analysis
via Western blot. To analyze luciferase activity a 50-l aliquot of intact cells
was mixed with 50 l of D-luciferin (Sigma) and buffered with 100 mM
potassium phosphate, pH 8.0. Each sample was vortexed for 10 s, and lumi-
nescence was collected for 10 s with a TD20/20 luminometer (Turner Designs,
Sunnyvale, CA).
Purification of Flag-tagged Ubr1
Flag-Ubr1 was affinity-purified from yeast as described (Du et al., 2002) with
modifications. BY4741 ubr1 cells expressing pYEplac181NTFlagUBR1 was
Table 1. Continued
Strain MAT Genotype Source
NNY47 a BY4741, ubr1::kanMX6, ubr2::HIS3, pRS425 CUP1.mycUB (LEU2) This study
NNY48  JN516, pRS425 CUP1.mycUB (LEU2) This study
NNY49  ssa1-45, pRS425 CUP1.mycUB (LEU2) This study
NNY50 a BY4741, pRS315 CPY* (LEU2) This study
NNY51 a BY4741, ubr1::kanMX6, pRS315 CPY* (LEU2) This study
NNY52 a BY4741, ubr2::kanMX6, pRS315 CPY* (LEU2) This study
NNY53 a BY4741, erg6::natMX4, pHis-Ste11N K444R (URA3), pRS425 CUP1.mycUB (LEU2) This study
NNY54 a BY4741, ubr1::kanMX6, ubr2::HIS3 erg6::natMX4, pHis-Ste11N K444R (URA3),
pRS425 CUP1.mycUB (LEU2)
This study
NNY55 a BY4741, san1::kanMX6, erg6::natMX4, pHis-Ste11N K444R (URA3) This study
NNY56 a BY4741, erg6::natMX4, pGAL-Arg--Gal (URA3) This study
a Huntsville, AL.
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grown to A600 of 1.5, centrifuged, and washed once in water. Cell lysis was
carried out in liquid nitrogen with glass beads. The ruptured cells were
dissolved in lysis buffer (10% glycerol, 0.05% Nonidet P-40, 0.2 M KCl, 50 mM
HEPES, pH 7.1, and 1 protease inhibitor cocktail from Roche). The affinity
purification was carried out with anti-FLAG M2 beads (Sigma). The cell lysate
was incubated on a nutator with the beads for 1 h at 4°C and washed five
times with lysis buffer. Flag-Ubr1 was eluted with 200 g/ml FLAG peptide
in lysis buffer without Nonidet P-40. The eluate was concentrated with a
30,000 molecular-weight cutoff Amicon centricon (Millipore, Bedford, MA).
The same procedure was carried out to purify Flag-Ubr1MR1 RING mutant.
Heat Denaturation of Firefly Luciferase and In Vitro
Ubiquitinylation
Recombinant firefly luciferase (Promega) was incubated at 4, 30, 37, and 42°C
for 30 min. Each of the different temperature-treated luciferases was added at
1.6 M to an ubiquitinylation reaction, which contained 230 nM affinity-
purified Flag-Ubr1, 45 nM human recombinant UBE1 (Boston Biochem, Bos-
ton, MA), 900 nM human recombinant UbcH2 (Boston Biochem), 4.8 M
32P-labeled PK-Ub, an ATP-regenerating system, 8.3 mM NaF, 1 phospha-
tase inhibitor cocktail 2 (Sigma), and 83 M human recombinant ubiquitin
aldehyde (BostonBiochem). The ubiquitin reaction was incubated at 30°C for
10 min before adding 32P-labeled PK-Ub. The ubiquitination was allowed to
proceed for 1 h at 30°C on a neutator. The reaction was quenched with 1%
SDS containing 10 mM NEM (Acros, Pittsburgh, PA) and 1 protease inhib-
itor cocktail (Roche). The quenched reaction was diluted to 0.1% SDS with IP
dilution buffer (60 mM Tris-HCl, 190 mM NaCl, 6 mM EDTA, pH 8.0, 1.25%
Triton X-100, 10 mM NEM), and 2.5 l of 10 mg/ml goat anti-luciferase
(Firefly) (Millipore) was added and incubated 3 h at 4°C on a nutator. This
was followed by the addition of 20 l of immobilized protein A/G beads
(Thermo Scientific, Waltham, MA) for another hour at 4°C on a nutator. The
beads were washed five times with IP dilution buffer and boiled in 2 sample
buffer containing ß-mercaptoethanol. The immunoprecipitated luciferase was
resolved on 4–20% SDS-PAGE (Bio-Rad, Richmond, CA) and fixed in 10%
glacial acetic acid and 40% methanol for 15 min. The fixed gel was washed
with water and treated with 1 M salicylic acid for 30 min before drying and
exposing to film.
Chemical Denaturation of Firefly Luciferase and In Vitro
Ubiquitinylation
Chemical denaturation was performed essentially as described (Silberg et al.,
1998). Luciferase, 13 g, was denatured by diluting it 10-fold in a luciferase
denaturation solution (25 mM HEPES, pH 7.5, 50 mM KCl, 5 mm MgCl2, 5
mM DTT, 6 M guanidine hydrochloride). The mixture was incubated at 25°C
for 1 h. As a control, 13 g of luciferase was treated similarly with luciferase
refolding solution (25 mM HEPES, pH 7.5, 50 mM KCl, 5 mm MgCl2, 1 mM
DTT, 1 mM ATP). Then the denatured luciferase and the control was diluted
100 fold in luciferase refolding solution. The denatured and diluted luciferase,
85 l, was used for the in vitro ubiquitination. The in vitro ubiquitination
was conducted as described previously with the following modifications.
The ubiquitination mixture contained 120 nM guanidine hydrochloride
treated or nontreated (control) luciferase, 37 nM Flag-Ubr1, 8 nM human
recombinant UBE1, 280 nM human recombinant UbcH2, 4.8 M 32P-
labeled PK-Ub, an ATP-generating system, 8.3 mM NaF, 1 phosphatase
inhibitor cocktail 2, and 83 M human recombinant ubiquitin aldehyde.
The ubiquitinylation reaction was incubated for 3 h at 30°C. The reaction
was quenched with 1% SDS. The IP with goat anti-luciferase was con-
ducted as described above.
Luciferase Aggregation Assay
Luciferase (100 nM) was incubated in 100 l assay buffer (25 mM HEPES,
25 mM KCL, 5 mM MgCl2, pH 7.4, 5 mM DTT, 2 mM ATP) with or without
Ubr1 (2 M) for 10 min at 25°C and shifted to 42°C for 10 min. The samples
were centrifuged at 20,000 rpm for 10 min at 4°C. The supernatant and
pellet fractions were separated by 10% SDS-PAGE and then transferred to
nitrocellulose membrane. Luciferase were detected by Western blot.
Flag Ubr1 Pulldown and CoIP of Luciferase
Luciferase (100 nM) was incubated in 100 l assay buffer (25 mM HEPES, 25
mM KCL, 5 mM MgCl2, pH 7.4, 5 mM DTT, 2 mM ATP) with Ubr1 (2 M) for
10 min at 25°C and then shifted to 42°C for 10 min. The reaction was diluted
to 300 l with assay buffer, followed by addition anti-FLAG resin (Sigma) for
a 20-min incubation with rocking at 4°C. The resin was washed with assay
buffer Ubr1 eluted with the FLAG peptide at 0.2 mg/ml.
Yeast carrying a galactose inducible luciferase plasmid along with either an
empty vector, or a plasmid containing Flag-Ubr1 under the ADH promoter
were allowed to grow to log phase at 30°C. Luciferase expression was induced
with 2% galactose. After 1 h of induction, 0.5 mg/ml cycloheximide was added
to samples. Half of each sample was allowed to remain at 30°C, and the remain-
ing yeast were heat-shocked at 42°C for 30 min. Yeast cultures were pelleted, and
whole cell lysate was extracted via bead breaking in a lysis buffer containing 0.1%
Triton. After normalization of whole cell lysates, Flag-Ubr1 was immunoprecipi-
tated with anti-Flag antibody. Protein samples were run on 7% SDS-PAGE gels,
and Western blotting was carried out, where membranes were probed for vari-
ous proteins as indicated. Inputs are 15% of total.
In Vitro Refolding and Ubiquitinylation of Firefly
Luciferase
Firefly luciferase, 200 nM, was mixed with 1 M Ssa1 and 3 M Ydj1 in the
luciferase refolding solution. The mixture was incubated at 42°C for 15 min to
denature the luciferase. The refolding reaction was carried out for 3 h at the
respective temperatures. Luciferase activity was measured at the end of the
refolding reaction using the luciferase assay system (Cat. no. E1501) from
Promega. After the refolding reaction, 30 nM Flag-Ubr1, 8 nM human recom-
binant UBE1, 280 nM human recombinant UbcH2, 4.8 M 32P-labeled PK-Ub,
an ATP-generating system, 8.3 mM NaF, 1 phosphatase inhibitor cocktail 2,
and 83 M human recombinant ubiquitin aldehyde were added to the mix-
ture and incubated for 2 h at 30°C. The reaction was quenched with 1% SDS.
Luciferase was immunoprecipitated with goat anti-luciferase. For the exper-
iments shown in Figure 6F, luciferase was denatured at 42°C for 10 min with
or without Ubr1 or HDM2. Subsequent ubiquitinylation assays were per-
formed in reaction buffer (20 mM HEPES, pH 7.4, 50 mM NaCl, 5 mM MgCl2,
2.5 mM ATP, 2 mM DTT) containing bovine ubiquitin (10 M), E1 (Calbio-
chem; 0.1 M), and 4 M E2 (ubc2; 4 M or Ubc5 0.4 M) Ubr1 (0.4 M), or
HDM2 (Boston Biochem; 0.4 M) was also added if not added during the
denaturation reaction. Reactions were incubated at 37°C for 2 h and termi-
nated by the addition of 25 l of SDS sample buffer to 25-l reactions. Proteins
were resolved on 10% SDS-PAGE gels, and Western blot analysis performed
with anti-luciferase.
Gap1 Permease Assays
Yeast strains were grown overnight in YPD media, washed with water,
resuspended in minimal media with proline to an A600 of 0.5, and grown for
90 min at 30°C. The cells were harvested, washed, and resuspended in 10 mM
citric acid buffer (pH 4.5) containing 2% glucose to an A600 of 2. Cell suspen-
sion, 0.5 ml, was incubated with 1 Ci [l-14C]citrulline (56.3 mCi/mmol) for
20 min at room temperature. After the reaction the cells were collected on
glass microfiber filters (Whatman, Clifton, NJ) and washed three times with
ice-cold water. The filters were dried, and the radioactivity on each filter was
measured after addition of scintillation fluid.
RESULTS
Ubr1 and Ubr2 Function in Degradation of Newly
Synthesized Unfolded Protein Kinases
A reverse genetic approach was used to identify ubiquitin
ligases that inhibit degradation of newly synthesized protein
kinases in yeast (S. cerevisiae) cells treated with GA, the
Hsp90 inhibitor. GA is a competitive inhibitor of Hsp90’s
ATPase, and its action results in the rapid degradation of
protein kinases and other clients by the ubiquitin/protea-
some system (Whitesell and Lindquist, 2005; Caplan et al.,
2007b). Yeast cells treated with GA were pulse-labeled with
[35S]methionine followed by a chase period. Protein kinases
were then immunoprecipitated from labeled cell extracts
(the input was normalized so that the same number of
counts per minute were in each sample) and resolved by
denaturing gel electrophoresis, and their levels visualized
by fluorography (Figure 1A). Tpk2 (a yeast homologue of
cAMP-dependent protein kinase) levels were similar in un-
treated and GA-treated samples, although the predominant
form in GA-treated cells was the immature (nonphosphory-
lated; slightly faster migration in a denaturing gel) com-
pared with the mature form from solvent-treated cells. After
a 1-h chase, Tpk2 levels were greatly diminished in the
presence of GA, and this effect was reversed by treatment
with the proteasome inhibitor, MG132 (Figure 1A). Tpk2
from solvent treated control cells was stable over the 1-h
chase period. Cmk2, a protein kinase whose stability is
chaperone-independent was not affected by GA treatment
(Mandal et al., 2007; Supplementary Figure S1A).
Yeast cells deleted for genes encoding different ubiquitin
ligases were then studied using the pulse-chase assay with
Tpk2 protein kinase as a substrate. Initial studies focused on
the N-end rule ubiquitin ligase, Ubr1. Although previous
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studies suggested that Ubr1 does not have a general func-
tion in the stress response (Bartel et al., 1990), those studies
did not test directly whether this ubiquitin ligase promoted
degradation of unfolded polypeptides. GA-induced degra-
dation of Tpk2 was therefore studied in an ubr1 strain after
pulse-chase analysis. The results of these experiments
showed that UBR1 deletion led to a reduced rate of Tpk2
degradation in the presence of GA (Figure 1, B and C).
Pulse-chase analysis demonstrated that the defect in degra-
dation was restricted to the first 10 min of chase and that a
wild-type rate of degradation resumed thereafter. This find-
ing suggests that Ubr1 promotes Tpk2 degradation shortly
after translation and was confirmed with studies of other pro-
tein kinases including Cdc28, Kss1, and Rim11 (Supplementary
Figure S1B). Further studies with the UBR1 paralog, UBR2,
revealed that it did not play the same role in GA-induced
degradation of Tpk2. UBR2 deletion failed to protect Tpk2
kinase at the 10-min chase period, although the overall rate of
degradation was reduced slightly in the ubr1/ubr2 double
mutant cells compared with the ubr1 mutant alone (Supple-
mentary Figure S1C). It is likely that Ubr2 does a play a role in
protein kinase degradation that is distinct from Ubr1, and this
will be discussed in greater detail below.
We tested whether Ubr1 functioned in protein kinase
degradation independently of GA treatment using a mutant
of the kinase-specific chaperone, CDC37. This molecular
chaperone protects the majority of newly made protein
kinases from degradation. In a cdc37S14A mutant, newly
made protein kinases are rapidly degraded via the ubiq-
uitin proteasome system (UPS), primarily during pulse-
labeling in a zero-point effect (Baker and Varshavsky, 1991;
Suzuki and Varshavsky, 1999; Xie and Varshavsky, 2002;
Mandal et al., 2007) Newly synthesized kinases such as Tpk2
appear after translation as a mixture of mature and imma-
ture forms (Mandal et al., 2007, 2008, see also Figure 1A). The
immature form is quickly degraded by the proteasome (Fig-
ure 2, A and C), whereas the mature form is stable. UBR1
deletion in cdc37S14A resulted in increased Tpk2 levels after
pulse-labeling, but in qualitative terms little was changed:
the kinase was predominantly in the immature form after
the pulse and in the mature form after a 1-h chase (cf. lanes
5 and 6 in Figure 2A). UBR2 deletion largely failed to prevent
degradation of Tpk2 in the cdc37S14A strain at the zero time point,
but did result in some accumulation of the immature form of
the kinase after 1 h compared with the cdc37S14A strain alone
(Figure 2A, cf. lanes 4 and 8). One possibility is that Ubr2
functions downstream of Ubr1 and promotes degradation of
residual immature Tpk2 that was not targeted for degrada-
tion via Ubr1. Deletion of UBR2 in wild-type cells did not
affect the rate of Tpk2 maturation (not shown).
The relative effect of deleting UBR1 or UBR2 genes on
Tpk2 levels described above was correlated with changes in
protein kinase activity using a peptide substrate. UBR1 de-
letion in cdc37S14A resulted in increased levels of Tpk2 ac-
tivity by  15% over cdc37S14A alone, whereas enzyme ac-
tivity was reduced in cdc37S14A/ubr2 mutants (Figure 2B).
Deletion of both UBR1 and UBR2 led to an intermediate
level of Tpk2 activity, but the apparent difference from the
cdc37S14A mutant was not statistically significant. We also
observed an increase in mature Tpk2 levels upon treatment
with the proteasome inhibitor, MG132 (Figure 2C). In this
case, proteasome inhibition led to an increase in mature
Tpk2 by 1.5-fold compared with the untreated cdc37S14A
cells. These results suggest that foldable conformers are
degraded in the cdc37S14A mutant and that blocking the
means of degradation can lead to some refolding.
Even though deletion of UBR1 or UBR2 resulted in differ-
ent amounts of active Tpk2 kinase in a cdc37S14A background
(Figure 2A), we noted that both mutants suppressed the
growth arrest phenotype of cdc37S14A at a restrictive growth
temperature of 34°C (Figure 2D). This effect was slightly
more pronounced in cdc37S14A mutants that were deleted for
both UBR1 and UBR2 suggesting an additive effect. The
results described above suggested that Ubr2 had a subordi-
Figure 1. Ubr1 functions in the degradation of newly synthesized protein kinases when Hsp90 is inhibited with geldanamycin. (A) Pulse-chase
analysis of HA-Tpk2 in wild-type cells treated with geldanamycin (GA; 50 M) and the proteasome inhibitor, MG132 (100 M) or solvent
alone. (B) Pulse-chase analysis of HA-tagged Tpk2 in wild-type and ubr1 cells treated with GA. Chase times shown in minutes. (C) Graph
of HA-Tpk2 degradation (n  3; error bars, SE).
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nate role to Ubr1 with respect to Tpk2 degradation. How-
ever, we also tested whether the difference in their respec-
tive functions reflected substrate specificity. Studies with
Rim11, Kss1, and Cdc28 suggested that Ubr2 did not play a
general role in protein kinase degradation (not shown), but
we did observe an effect with a recombinant catalytically
inactive kinase, Ste11NK444R (Flom et al., 2008). As with
Tpk2, Ste11NK444R levels are diminished in the cdc37S14A
mutant during pulse-labeling in a zero-point effect (Figure
2E), with very little subsequent decrease in kinase levels.
However, the zero-point degradation was partially sup-
pressed by deletion of UBR1 or UBR2, albeit to different
extents (and also by MG132; not shown). In this case, the
effect of UBR2 deletion was more pronounced than with
Figure 2. Ubr1 and Ubr2 promote protein kinase degradation in a cdc37S14A mutant. (A) Pulse-chase analysis of Tap-tagged Tpk2 in
wild-type (WT), cdc37S14A (cdc37) mutant cells in the presence and absence of UBR1 (ubr1) and UBR2 (ubr2). 0 and 1 represent times of
chase after a 10-min pulse-labeling with [35S]methionine. M, mature and I , immature forms of Tap-tagged Tpk2. (B) Tpk2 activity was
measured after IP of Tap-tagged Tpk2 from cell lysates. Assays performed using PepTag nonradioactive detection system. Lysates were from
cdc37S14A (cdc37) with and without UBR1 and/or UBR2 as indicated. Results presented as percentage of activity in a wild-type strain.
Statistical significance, **p   0.01; n  8. (C) Effect of the proteasome inhibitor, MG132, on Tap-tagged Tpk2 maturation. Chase time shown
in minutes. M, mature and I, immature form of the kinase. The relative amount of immature and mature forms are indicated beneath the
panel. (D) Assay of yeast cell growth. Tenfold serial dilutions were plated onto YPD plates and incubated at 30 or 34°C as indicated for 3 d.
(E) Pulse-chase analysis of Ste11NK444R. Chase times indicated in minutes. Graph at right shows combined results from four independent
experiments. Bars, SE.
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deletion of UBR1, thereby demonstrating substrate prefer-
ence between these two E3 ligases. Western blot analysis
confirmed these results and showed increased levels of
Ste11NK444R in cdc37S14A/ubr1, cdc37S14A/ubr2, and
cdc37S14A/ubr1/ubr2 mutants compared with the cdc37S14A
mutant alone (not shown and Supplementary Figure S3F).
These combined results show that Ubr1 and Ubr2 display
substrate specificity and may also function in both zero
point and slower degradation pathways.
We also analyzed whether Ubr1 and Ubr2 functioned in
degradation pathways distinct from those originating from
cytosolic ribosomes. To this end we investigated CPY*, a sub-
strate for the ER-associated degradation pathway (ERAD;
Hiller et al., 1996). However, neither Ubr1 nor Ubr2 function
in ERAD because CPY* degradation was unaffected by de-
letion of either gene (Supplementary Figure. S1D). These
findings also show that general attributes of the UPS are
unaffected by deletion of UBR1 or UBR2.
Ubr1 functions via recognition of N-degrons that are re-
vealed after removal of the N-terminal methionine, as well
as internal degrons (Bartel et al., 1990; Mogk et al., 2007). We
therefore analyzed how deletion of other N-end rule path-
way components affected degradation of an unfolded Tpk2
synthesized in the presence of GA. Genes encoding the
ubiquitin-conjugating enzyme (E2) RAD6, arginyl-tRNA
protein transferase (ATE1) as well as two other E2 enzymes
known to be important for unfolded protein degradation,
UBC4 and UBC5 were studied. Tpk2 levels were monitored
after pulse-labeling and after a 10-min and a 1-h chase in
untreated cells and in cells treated with 50 M GA. The
pulse and chase reactions are aligned separately by strain in
Figure 3, A and B, for direct comparison of the effects of each
Figure 3. Ubr1 functions in protein kinase degradation in associa-
tion with Rad6. (A) Pulse and 10-min chase analysis of HA-Tpk2 in
wild-type (WT) and mutant yeast strains as indicated in the absence
and presence of 50 M GA. Quantitation of band intensity shown in
bar graph below panel. (B) As in A., except that chase period was 1 h.
Data are from three independent experiments (*p  0.05; **p  0.01).
(C) Growth of strains in 10-fold serial dilution at 30 and 34°C on YPD
plates as indicated.
N. B. Nillegoda et al.
Molecular Biology of the Cell2108
gene deletion on Tpk2 kinase levels. The data were quanti-
fied and presented in bar graph form in Figure 3, A and B.
After a 10-min chase, there was a statistically significant rise
in Tpk2 levels in strains deleted for UBR1 (by 19%) and
RAD6 (by 10%) compared with the wild type (Figure 3A).
After 1 h of chase there was a small but statistically signif-
icant rise in Tpk2 levels in the ubc4 strain (by 5%), in
addition to ubr1 (by 17%) and rad6 (by 20%) strains com-
pared with the wild type (Figure 3B). Previous studies have
shown that the E2 Rad6 binds directly to Ubr1, whereas
other studies suggest a functional association between Ubc4
and Ubr1 (Byrd et al., 1998; Xie and Varshavsky, 1999). These
findings provide supporting evidence for a direct role of
Ubr1 in the degradation of unfolded protein kinases, be-
cause its cognate E2, Rad6, is also involved. Ate1, by con-
trast, which acts in the N-end rule pathway does not appear
to play a role in protein kinase degradation.
Deletion of UBR1 in the cdc37S14A mutant led to improved
cell growth at 34°C, as shown in Figure 2. We anticipated
that double mutants between cdc37S14A with rad6 and
ubc4 would exhibit a similar phenotype because there were
increased kinase levels in these strains due to defective
degradation. This was tested by growth analysis on solid
media (Figure 3C), and our prediction was borne out in the
case of cdc37S14A/ubc4 cells (Figure 3C, arrowheads). In
this case the growth suppression is more robust than for
ubr1/cdc37S14A cells. By contrast, double mutants of rad6
and cdc37S14A did not have better growth at 34°C compared
with cdc37S14A alone. This may be due to the pleitotropic
roles of Rad6 in genome integrity (Lee and Myung, 2008).
Interestingly, the cdc37S14A mutant has synthetic growth
defects with several other genes involved in genome integ-
rity (Caplan et al., 2007a). Therefore, it is possible that any
protein kinase refolding due to deletion of RAD6 in the
cdc37S14A mutant is masked by other defects affecting cell
growth. A synthetic growth defect was also observed in
cdc37S14A/ate1 cells and cdc37S14A/nta1 cells (Supplemen-
tary Figure S2A).
Further studies investigated more directly whether the
N-end rule pathway itself influenced Ubr1 function in pro-
tein kinase degradation. Previous studies demonstrated that
dipeptides Arg-Ala and Leu-Ala inhibited N-end rule sub-
strate degradation by binding to type I and type II sites,
respectively. They also relieved autoinhibition of a third
Ubr1 substrate-binding site for Cup9, a transcriptional re-
pressor (Baker and Varshavsky, 1991; Du et al., 2002). Ad-
ministration of both dipeptides stimulates Cup9 degrada-
tion in wild-type cells as shown in Figure 4A, as expected.
However, these dipeptide inhibitors of the N-end rule sites
had no effect on GA-dependent Tpk2 degradation, provid-
ing further support that Ubr1 functions independently of the
N-end rule pathway. A similar conclusion can be drawn
from a direct analysis of an N-end rule substrate, in this case,
Arg-ß-Gal (Xie and Varshavsky, 1999; Arg-ß-Gal; Figure 4B).
Arg-Ala and Leu-Ala dipeptides led to increased levels of
Arg-ß-Gal at time zero, but had very little effect on Tpk2
degradation. Further evidence for N-end rule–independent
degradation of unfolded Tpk2 came from studying this ki-
nase in N- and C-terminal–tagged forms in the presence of
GA. In each case deletion of UBR1 had a similar effect on
suppressing the degradation (Figure 1, three used N-termi-
nal HA-tagged Tpk2, and similar findings were made using
C-terminally tagged Tpk2-TAP; Supplementary Figure S2B).
Ubr1 and Ubr2 Act Redundantly to Promote
Ubiquitinylation of Unfolded Polypeptides
To test whether Ubr1 and Ubr2 function more broadly in
degradation of newly synthesized proteins, we induced a
stress response with AZC (Trotter et al., 2001, 2002). AZC is
a proline analogue that incorporates competitively with l-
proline; this reduces polypeptide thermal stability (Zagari et
al., 1994) and results in increased levels of newly synthesized
polypeptides binding to Hsp70 (Beckmann et al., 1990). Our
approach was to pulse-label cells expressing myc-tagged
ubiquitin with 35S-met in the absence and presence of 50 mM
AZC. This was followed by IP of ubiquitinylated polypep-
tides with anti-myc. Newly synthesized polypeptides that
became ubiquitinylated during or shortly after translation
were visualized after denaturing gel electrophoresis and phos-
phorimaging (Figure 5). Wild-type cells treated with AZC un-
der pulse-labeling conditions have increased amounts of
polyubiquitinylated proteins by about twofold. The level of
ubiquitinylation induced by AZC was decreased only
slightly by deletion of UBR1 or UBR2 alone. By contrast,
strains deleted for both genes were largely unable to re-
spond to AZC, and the level of polyubiquitinylation in these
cells was almost unchanged. Cells treated with AZC had
similar viability (Supplementary Figure S3A). Uptake of
[35S]methionine was similar in ubr1/ubr2 compared with
the wild type, although the profile of proteins synthesized in
the presence of AZC was slightly different (Supplementary
Figure S3B). In addition, similar amounts of unconjugated
myc-Ubiquitin were observed in wild-type and ubr1/
Figure 4. Ubr1 functions in protein kinase
degradation independently of the N-end rule.
(A) Analysis of Cup9 and Tpk2-TAP degra-
dation in the absence and presence of dipep-
tides Arg-Ala and Leu-Ala (10 mM each).
Pulse-chase analysis shown at the indicated
times in the presence of 50 M GA. (B) As in
A, except that the N-end rule substrate, Arg-
ß-Gal was analyzed in comparison with HA-
Tpk2 in the presence of GA (50 M) and
Arg-Ala/Leu-Ala dipeptides.
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ubr2 double mutant cells (Supplementary Figure S3B), and
the levels of general ubiquitinylation appeared unaffected
by AZC in either cell type (Supplementary Figure S3C).
Further control experiments showed that AZC could enter
the ubr1/ubr2 cells in a manner similar to the wild type,
based on its ability to compete for import of 14C-labeled
citrulline (Lauwers et al., 2007), which like AZC is trans-
ported via the general amino acid transporter, Gap1
(Hoshikawa et al., 2003; Supplementary Figure S3D). Further-
more, the effect of AZC was different from the proteasome
inhibitor MG132 alone, where no increase in ubiquitinylated
proteins were observed in wild-type cells (Supplementary Fig-
ure S3E). Further experiments tested whether ubiquitinylation
of a protein kinase was affected by deletion of UBR1 and UBR2.
Ste11NK444R was immunoprecipitated from wild-type and
ubr1/ubr2 strains expressing myc-tagged ubiquitin treated
with and without GA and MG132 (Supplementary Figure S3F).
The level of Ste11NK444R was higher in the ubr1/ubr2 strain
compared with the wild type and was increased further by
MG132 treatment. Nevertheless, there was 20% less ubiq-
uitinylation of the protein kinase in the ubr1/ubr2 strain
compared with the wild type after normalization of kinase
levels.
Ubr1 and Ubr2 Promote Degradation of Mature Proteins
That Become Denatured
Ubr1 and Ubr2 were shown above to function in quality
control of newly synthesized polypeptides. We next tested
whether this property was exclusive or whether Ubr1/Ubr2
function extended to previously folded proteins that become
denatured. Our first approach was to adapt the assay in-
volving IP of myc-Ub from cells pulse-labeled with 35S-Met
(Figure 5). In this case, however, the pulse-labeled cells were
chased with cold methionine and cycloheximide for 30 min
to allow sufficient time for folding of the 35S-labeled pro-
teins. These cells were subsequently heat stressed at 42°C for
30 min. In a recent study, heat stress was found to induce a
modest increase in protein degradation, by 10–13% (Medi-
cherla and Goldberg, 2008). In this case, newly made pro-
teins remained sensitive to degradation for 30–60 min. Our
results are consistent with this (Figure 6A), and the amount
of 35S-labeled protein immunoprecipitated with anti-Myc
was increased by 10% after heat shock compared with a
non-heat-shocked control (n  5, p  0.014). By contrast
there was no statistically significant change in ubiquitinyla-
tion of heat-shocked proteins in ubr1/ubr2 cells. This find-
ing suggests that Ubr1 and Ubr2 function is not restricted to
newly synthesized proteins.
In another test, we monitored luciferase levels and activity
after heat shock in vivo at 42°C, which is a denaturing
condition. Cycloheximide was added to the cells before heat
shock, and luciferase recovery was measured after 2 h. This
was performed in cells deleted for UBR1 and UBR2 and the
double mutant strains, and the data compared with a non-
heat-shocked control for each strain. Our findings showed
that luciferase levels and activity were higher in the ubr1,
ubr2, and double mutant cells compared with the wild type
after the 2-h recovery after heat shock (Figure 6, B–D).
Notably, increased levels of luciferase occurred in each of
the single mutants, although no additive effect was ob-
served. These findings may suggest collaborative action be-
tween Ubr1 and Ubr2 in some circumstances.
Ubr1 Displays Specificity for a Denatured Substrate
The function of Ubr1 and Ubr2 could be direct or indirect
based on our genetic studies. We therefore investigated
whether Ubr1 had preference for unfolded versus native
protein substrates in vitro. Luciferase was used as a test
substrate because it denatures readily. FLAG-Ubr1 was af-
finity-purified from yeast (Supplementary Figure S4A) and
added to ubiquitinylation reactions containing human Ube1
(E1), UbcH2 (human Rad6 homolog), and 32P-labeled ubiq-
uitin (Tan et al., 1999). Reactions containing equal amounts
of luciferase were incubated at 30°C followed by IP with
anti-luciferase, followed by denaturing gel electrophoresis
and fluorography. Studies with native luciferase revealed
very little ubiquitinylation (Figure 7A). However, when lu-
ciferase was first denatured with guanidinium hydrochlo-
ride, there was a substantial increase in the amount of
mono-, di-, and polyubiquitinylated species. The latter are
observed as a smear above the mono- and diubiquitinylated
forms of luciferase. The specificity of this reaction was de-
termined by adding each reaction component separately. As
shown in Figure 7B, a small amount of monoubiquitinylated
luciferase was observed in the presence of the E1 and E2
alone. However, this was increased by addition of Ubr1 to
the reaction. Furthermore, a previously described RING do-
main mutant of Ubr1, MR1 (C1220S; Xie and Varshavsky,
1999), had a reduced ability to polyubiquitinylate denatured
luciferase in the purified system (Figure 7B). The specificity
of the E2 enzyme was addressed by performing the reactions
with different Ubc enzymes. We observed that only UbcH2
was functional in this assay, although a small amount of
activity occurred with UbcH5 enzymes, which are the hu-
man orthologues of Ubc4 and Ubc5 (Jensen et al., 1995;
Supplementary Figure S4B).
Further studies addressed luciferase ubiquitinylation us-
ing heat as a denaturing factor (Schroder et al., 1993). Native
luciferase was preincubated at temperatures ranging from 4
to 42°C for 30 min and then split into two aliquots: one for
measurement of luciferase activity and one for an ubiquiti-
nylation reaction performed at 30°C. As shown in Figure 7C,
there was a substantial incorporation of 32P-ubiquitin into
luciferase preincubated at 37 and 42°C, but not at 4 or 30°C.
Activity measurements of luciferase after the preincubations
revealed that all luciferase was denatured after the 42°C
preincubation and 55% was denatured after the 37°C incu-
bation. Notably, the 42°C preincubation reaction was turbid,
suggesting that the luciferase was largely aggregated. Tur-
Figure 5. Ubiquitinylation of newly synthesized polypeptides in
the presence of AZC requires Ubr1 and Ubr2. Analysis of ubiquiti-
nylation of newly synthesized polypeptides after a 10-min pulse-
labeling in the absence () and presence () of 50 mM AZC.
Polyubiquitinylated polypeptides (poly-Ub) were immunoprecipi-
tated with anti-myc and resolved in a 4–20% denaturing gel before
phosphorimaging. Strains used were wild-type (WT), ubr1, ubr2,
and ubr1/ubr2 double mutants.
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bidity was noted also in the 37°C preincubation but to a
lesser extent.
The findings described above show that Ubr1 displays
specificity toward denatured luciferase over the native en-
zyme. Further studies addressed whether it does so by direct
interaction with the denatured form of luciferase. To this
end, luciferase was denatured in the absence or presence of
Ubr1. The reactions were centrifuged to pellet aggregates,
Figure 6. Ubr1 and Ubr2 promote ubiquitinylation and degradation of mature proteins after heat stress. (A) Wild-type (WT) and
ubr1/ubr2 cells were pulse-labeled for 10 min and chased with cycloheximide and cold methionine for 30 min. Cells were then incubated
at 30 (control) or 42°C (HS) for 30 min. 35S-labeled ubuiquitinylated proteins were immunoprecipitated with anti-Myc and resolved on
denaturing gels. The relative amount of ubiquitinylation (fold increase after heat shock) is shown in the bar graph (n  5; *p  0.014). (B)
Luciferase was expressed from a galactose-inducible promoter in WT , ubr1, ubr2, and ubr1/ubr2 strains for 2 h. Samples were treated
with 0.5 mg/ml cycloheximide, heat shocked (HS) for 60 min at 42°C, and then returned to 30°C for a recovery period. Total protein levels
(B and C) of luciferase were monitored before HS, directly after heat shock, and at 2 h after heat shock. Hsp104 is shown as a loading control.
(D) Luciferase activity was monitored at the same time points (as described in Materials and Methods). Activity is given as a percent of no heat
shock control within each strain background. The data in C and D are plotted as means of three independent experiments. The Western blot
shown in B is a representative of the averaged experiments.
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and these were resuspended to determine the amount of
luciferase in both pellet and supernatant fractions. These
studies revealed that Ubr1 largely prevented luciferase ag-
gregation as demonstrated by the reduced amount in the
pellet fraction (Figure 7D). Direct binding of denatured lu-
ciferase to Ubr1 was also observed in a pulldown reaction
(Figure 7E). On the basis of these observations, we propose
that Ubr1 acts to promote ubiquitinylation of denatured
proteins via direct chaperone-like interactions. We next de-
termined whether Ubr1 interaction with the substrate dur-
ing denaturation influenced its activity. As shown in Figure
7F, there was a dramatic increase in luciferase ubiquitinyla-
tion when Ubr1 was present during the denaturation reac-
tion compared with when it was added afterward (cf. Figure
7F, lanes 3 and 4). Heat treatment of Ubr1 did not increase its
activity (data not shown), so Ubr1 appeared to maintain
denatured luciferase in a ubiquitinylation competent state
during heating. Importantly, another E3 ligase, HDM2 was
unable to ubiquitinylate luciferase when added during or
after the denaturation (Figure 7F, lanes 6 and 7), although it
Figure 7. Binding and ubiquitinylation of denatured luciferase by Ubr1. (A) Purified luciferase was kept native or denatured with
guanidinium hydrochloride (GnHCl) before an ubiquitinylation reaction with Ubr1, Ube1, and UbcH2 and 32P-labeled ubiquitin. Reactions
were immunoprecipitated with anti-luciferase and were resolved on a denaturing gel before being visualized by autoradiography. Arrow
denotes monoubiquitinylated luciferase. (B) Denatured luciferase was incubated with different components of the ubiquitinylation reaction
as indicated. A RING mutant of Ubr1, MR1, was also used in this experiment. (C) Purified luciferase was preincubated at the indicated
temperatures for 30 min before being split into two aliquots. One was added to an ubiquitinylation reaction containing Ubr1, Ube1 (E1),
UbcH2 (E2), and 32P-labeled ubiquitin (top panel). The second aliquot was used to measure remaining luciferase activity (graph in bottom
panel). The bars represent luciferase activity as a percentage of the aliquot maintained at 4°C. (D) Purified luciferase was incubated with or
without Ubr1 before denaturation at 42°C. The total reaction (T) was separated into supernatant (S) and pellet (P) fractions after
centrifugation. The amount of luciferase in each fraction was determined by Western blot. (E) Luciferase was kept native or denatured at 42°C
in the absence or presence of Ubr1. Ubr1 was immunoprecipitated, and the amount of luciferase that coimmunoprecipitated was determined
by Western blot. (F) Ubiquitinylation of luciferase when Ubr1 is present during the denaturation step. Luciferase was denatured by
incubation at 42°C by itself (lane 1) or in the presence of Ubr1 (lane 4) or HDM2 (lane 7). The luciferase was then added to reactions containing
E1 and Ubc2 (lane 2); E1, Ubc2, and Ubr1 (lane 3); E1 and Ubc5 (lane 5); and E1, Ubc5, and HDM2 (lane 6). All reactions contained ATP and
ubiquitin. Luciferase was visualized by Western blot. Arrow denotes nonubiquitinylated luciferase. (G) IP of Flag-Ubr1 and Western blot for
coimmunoprecipitating luciferase before and after heat shock at 42°C for 30 min.
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had a similar capacity as Ubr1 to catalyze ubiquitin chain
assembly nonspecifically (not shown). This demonstrates the
specificity of Ubr1 toward unfolded proteins.
To further address whether Ubr1 has a direct function in
luciferase degradation in vivo, we tested whether denatured
luciferase could be specifically immunoprecipitated with
Ubr1 from cell extracts. Our approach was to use heat shock
as a source of denatured luciferase, and our findings were
that only this form of the enzyme coimmunoprecipitated
with Ubr1, whereas the native enzyme from non-heat-
shocked cells could not (Figure 7G).
Hsp70 Stimulates Polyubiquitinylation by Ubr1
Previous studies demonstrated that some molecular chaper-
ones function in both folding and degradation pathways,
suggesting that decisions regarding this fate will be deter-
mined in part by them. A likely candidate in this regard is
Hsp70, which interacts with many newly synthesized
polypeptides. We therefore addressed whether Hsp70 was
required for ubiquitinylation in reactions known to involve
Ubr1 and Ubr2. To this end, we used the ssa1-45 mutant
(Becker et al., 1996) that was shown previously to be defec-
tive for degradation of proteins in the cytosol and those
exported from the ER (Huyer et al., 2004; McClellan et al.,
2005; Han et al., 2007; Nakatsukasa et al., 2008). As shown in
Figure 8A, ssa1-45 cells are also defective for ubiquitinyla-
tion of newly synthesized polypeptides induced by adding
AZC to cells before pulse-labeling. This was not due to
decreased protein synthesis, and general levels of ubiquiti-
nylation were unaffected (Supplementary Figure S4C).
We also analyzed whether purified Hsp70 promoted ubiq-
uitinylation of luciferase by Ubr1 in the purified system. As
shown in Figure 8B, incubation of luciferase with Hsp70
(yeast Ssa1) during denaturation but before the ubiquitiny-
lation reaction promoted subsequent polyubiquitinylation
by Ubr1. A similar finding was made with chemically dena-
tured luciferase, although in this case the chaperone was not
present during the denaturation itself, but in the subsequent
incubation (not shown). This effect was not observed with
Ydj1, an Hsp40 chaperone partner of Hsp70 (Cyr, 1995).
Furthermore, when the incubation was performed with both
chaperones even under refolding conditions (Figure 8B, left
panel), we observed partitioning between both refolding
and ubiquitinylation fates during the subsequent ubiquiti-
nylation reaction. The actions of Hsp70 in promoting ubiq-
uitinylation of luciferase were enhanced when the chaper-
one incubation was performed at 37°C, where refolding is
not favored (Figure 8C). These findings suggest that Hsp70
is important for ubiquitinylation by Ubr1.
DISCUSSION
Quality control processes contribute to the etiology of sev-
eral late-onset diseases from neurodegenerative conditions
to diabetes and cancer. The best-described quality control
process is ERAD, for which several components of the UPS
have been shown to act in a specific manner (Vembar and
Brodsky, 2008). By contrast, much less is known about quality
control of polypeptides emerging from cytosolic ribosomes.
Eisele and Wolf (2008) recently showed that Ubr1 functioned in
Figure 8. Hsp70 promotes ubiquitinylation by Ubr1. (A) Ubiquitinylation of newly synthesized polypeptides in the absence () and
presence () of AZC in strains expressing myc-tagged ubiquitin. IP of 35S-labeled polypeptides with anti-myc is shown. Strains used were
wild type (JN516; SSA1) and ssa1-45. Bar graph below panel indicates levels of induction of ubiquitinylated newly synthesized polypeptides.
Bars, SE; n  3. (B) Ubiquitinylation reaction of heat-denatured luciferase using 32P-labeled ubiquitin. Purified Ssa1 (5:1 with luciferase) or
Ydj1 (15:1 with luciferase) were added to the heat denaturation reaction, followed by a further incubation (“chaperone incubation”) and the
subsequent ubiquitinylation reaction using 32P-labeled ubiquitin as indicated. In this reaction, the denaturation was followed by chaperone
and ubiquitinylation reactions both at 30°C. The reaction was split into two before the ubiquitinylation reaction. One-half was used for the
ubiquitinylation reaction, and the second half used for assays of luciferase activity, shown in the graph below the panel. (C) Same as B, except
that the chaperone reaction was performed at 37°C.
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the degradation of a mislocalized ER protein. While this article
was in preparation, Hampton and colleagues revealed that
Ubr1 and San1 ubiquitin ligases also promote degradation of
unfolded cytosolic proteins (Heck et al., 2010). In this report,
we describe the actions and mechanisms underlying Ubr1 and
Ubr2 in the cytosol. Perhaps most importantly, we demon-
strate here that Ubr1 recruits unfolded polypeptides directly
(Figure 7). Similarly, the chaperone action of Hsp70 also con-
tributes to substrate ubiquitinylation via Ubr1.
Our findings support a novel role for Ubr1 in the quality
control process that is independent of the N-end rule. Ubr1
selectively binds to nonnative proteins and suppressed their
aggregation. It is also active in the degradation of misfolded
proteins under conditions where action of the N-end rule
pathway is blocked. For example, we can inhibit N-end rule
type I and type II binding sites with dipeptides, but this does
not affect GA-dependent protein kinase degradation. Tpk2
kinase degradation is partially inhibited in the ubr1 strain
independently of having epitope tags on the N- or C-termi-
nus. Nor is there any role for Ate1 in the cytosolic quality
control system (Figure 3).
The biochemical mechanisms underlying Ubr1 action are
not limited to its own chaperone-like function by interacting
directly with unfolded substrates. Hsp70 also plays a role in
this process, and our experiments with luciferase underscore
the point because the chaperone promotes Ubr1-dependent
polyubiquitinylation. The most likely explanation for the
role of Hsp70 is that it prevents luciferase aggregation and
presents the substrate to Ubr1. However, not all chaperones
have the same ability. Ydj1, for example, was unable to
promote luciferase ubiquitinylation (Figure 8). This is con-
sistent with our prior observations that Ydj1 protects newly
synthesized protein kinases from degradation in vivo (Man-
dal et al., 2008). It is clear, however, that Ydj1’s protective
actions are not universal, because several earlier reports
showed that it is required for protein disposal (Lee et al.,
1996; Huyer et al., 2004; McClellan et al., 2005; Han et al.,
2007; Nakatsukasa et al., 2008). This has been demonstrated
for normally cytosolic proteins and ERAD substrates. Simi-
lar findings have been made for Hsp90 (Gusarova et al.,
2001). In our case, we observed that Hsp70 could participate
in both folding and degradation reactions at the same time.
It seems likely, therefore, that different chaperone assem-
blies display substrate specificity for folding or degradation
targeting functions.
In addition to the biochemical characterization of Ubr1/
Ubr2 function in cytosolic quality control, our results also
reveal how this process contributes to growth. This was
evident in the way that deletion of UBR1 and UBR2 resulted
in phenotypes that may be viewed as opposite to those
observed in strains deleted for molecular chaperones. Dele-
tion of UBR1 or UBR2 partially suppressed the growth arrest
phenotype of a cdc37S14A mutant strain. One interpretation
of these findings is that foldable conformers of unfolded
proteins were saved from rapid degradation because their
ubiquitinylation was prevented. Alternatively, it is also pos-
sible that changes in transcription due to stabilization of
Cup9 and Rpn4, in ubr1 and ubr2 strains, may also play a
role. Evidence for the first explanation comes from direct
assessment of Tpk2 kinase activity in cdc37S14A cells that
were also deleted for UBR1. In this case we observed a small
but significant rise in enzyme levels and activity when deg-
radation was inhibited (Figure 2). In addition, greater levels
of luciferase activity were recovered subsequent to a dena-
turing heat shock in strains deleted for UBR1 or UBR2
(Figure 6). A similar finding was made for a mutant of the
cystic fibrosis transmembrane regulator (CFTR) in animal
cells, because blocking its ubiquitinylation led to greater
levels of active CFTR (Younger et al., 2004). Furthermore, a
recently characterized juxtanuclear quality control compart-
ment, named JUNQ, accumulates misfolded proteins in a
soluble form that is largely, although not completely depen-
dent on their ubiquitinylation (Kaganovich et al., 2008).
Suppression of the cdc37S14A mutant growth arrest phe-
notype by UBR1 or UBR2 deletion supports the hypothesis
that protein kinase degradation in this strain leads to poor
growth. However, given that foldable conformers are de-
stroyed, the pathway must be very efficient; indeed, there
have been reports of rapid biphasic degradation of unstable
recombinant proteins (Xie and Varshavsky, 2002) and pro-
tein kinases in yeast (Mandal et al., 2007, 2008). This suggests
that there is a trade-off between growth potential and accu-
mulation of unfolded or misfolded proteins built into cyto-
solic quality control. In the case of the cdc37S14A mutant, the
quality control system so efficiently removes unfolded
newly synthesized protein kinases that the cell has reduced
growth, even though their potential for folding still exists
(Figure 2). We speculate that the efficiency of the quality
control system matches the potential for toxicity of unfolded
or misfolded proteins. Our model, therefore, is that Hsp70
plays a central role in cytosolic quality control. Without
protection from other chaperones such as Ydj1 or Cdc37 or
under stress, the degradation pathway is favored by direct
interaction of the polypeptide with Ubr1/2 or via Hsp70
itself. The physiological consequence, as deduced from stud-
ies with Cdc37, is reduced growth as degradation increases.
Comparison of our results with the recent studies of Heck
et al. (2010) shows many similarities and some differences.
The main difference is that we observed a role for Ubr2 in
cytosolic quality control processes whereas they did not.
Furthermore, they described how Ydj1 promotes degrada-
tion while we showed previously that Ydj1 protects newly
synthesized protein kinases from that fate (Mandal et al.,
2008). One clear difference between our studies and those of
Heck et al. (2010) is that we studied predominantly wild-
type proteins (e.g., Tpk2) whose folding pathways are
blocked (with the exception of the AZC experiment shown
in Figure 5), while they studied mutant proteins or proteins
mislocalized from other compartments. Heck et al. (2010)
also demonstrated a role for the nuclear ubiquitin ligase,
San1, in quality control of cytosolic proteins. Indeed, we also
observed reduced degradation of a protein kinase in san1
cells (Supplementary Figure S5).
In mammalian cells, rapid degradation of newly synthe-
sized proteins has also been observed, but in a constitutive
manner (Schubert et al., 2000; Qian et al., 2006). Although
different interpretations on the significance of this finding
have been made (Vabulas and Hartl, 2005; Yewdell and
Nicchitta, 2006), it seems likely that the cytosolic quality
control system is conserved. Several Ubr-related proteins are
expressed in mammalian cells (Tasaki et al., 2005). Testing
whether age-related decreases in mammalian quality control
processes contribute to late-onset disease states is a clear
direction for future studies.
The identification of Ubr1 and Ubr2 in cytosolic quality
control process represents a novel function for these ubiq-
uitin ligases. It is clear that they do not act alone, however,
and that other ubiquitin ligases must function to clear mis-
folded polypeptides. Such is the case for ERAD where sev-
eral distinct E3 ubiquitin ligases promote degradation,
sometimes acting on distinct domains of substrate polypep-
tides (Younger et al., 2006). The identities of other ubiquitin
ligases that function alongside Ubr1 and Ubr2 remain to be
determined.
N. B. Nillegoda et al.
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